Global
This presentation is the property of its rightful owner.
Sponsored Links
1 / 7

Paclitaxel Injection Market Segmentation, Analysis and Forecast 2020 PowerPoint PPT Presentation


fide (ZnS) are well known for their applications in electrical, optical and chemical industries. The present study was aimed to evaluate the impact of biofield treatment on the structural and physical properties of BaO and ZnS powder. The study was carried out in two groups, one was set to control, and another group was subjected to Mr. Trivedi’s biofield treatment. Control and treated samples of BaO and ZnS were analyzed using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), and surface area analyzer. XRD data showed that lattice parameter and unit cell volume of BaO powder were reduced upto 0.42% and 1.26%, respectively as compared to control.Biofield, Biofield EnergyTreatment, Mahendra Kumar Trivedi, The Trivedi Effect, Zinc Sulfidek2308066_A6influenceofbiofieldtreatmentonphysicalandstructuralcharacteristicsofbariumoxideandzincsulfide.pdf4public0| 5 |0ŮůoVare its capability to be utilized for treatment for different sorts of tumors.View Sample Report@ http://www.bigmarketresearch.com/paclitaxel-injection-market

Download Presentation

Paclitaxel Injection Market Segmentation, Analysis and Forec...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Paclitaxel injection market segmentation analysis and forecast 2020

GlobalPaclitaxel Injection Market

Opportunities and Forecasts, 2013 - 2020


Paclitaxel injection market segmentation analysis and forecast 2020

REPORT DESCRIPTION

The report provides market analysis, information and insights into “Paclitaxel Injection Market ”

Paclitaxel belongs to the group of medications known as antineoplastics and is used in the treatment of cancers. It works by inhibiting the growth of cancer cells and is used in the treatment of various cancers such as breast cancer, ovarian cancer, non small cell lung cancer, etc. According to the WHO, cancer was the leading cause of death worldwide, accounting for the death of 8.2 million people in 2012. The major drivers for this market are the rising incidence of cancer globally and the improved efficacy of paclitaxel injections. However, adverse drug reactions associated with the drug as well as the emergence of targeted treatment, personalized medicine and novel anti-cancer drugs would be a challenge to the growth of this market. The opportunities for this market are its potential to be used for treatment for various types of cancers.

View Sample Report@ http://www.bigmarketresearch.com/paclitaxel-injection-market


Paclitaxel injection market segmentation analysis and forecast 2020

KEY MARKET BENEFITS

  • Market segmentation by use of the product would help in identification of future applications

  • Porter’s five force model helps in making strategic business decisions for business development

  • In-depth geographic Analysis would aid in identifying regions where demand for this product would increase

  • In-depth analysis of drivers and opportunities would help in understanding the future potential of this market


Paclitaxel injection market segmentation analysis and forecast 2020

KEY MARKET SEGMENTS

Paclitaxel Injection Market by use in treatment of various cancers

Paclitaxel Injection is used in the treatment of Breast cancer, Ovarian cancer, Non small cell lung cancer, AIDS related Kaposi's sarcoma, Cervical Cancer, Esophageal cancer, Prostate cancer , Stomach cancer, Testicular cancer, Lung cancer, Pancreatic cancer, and Others. According to the WHO, stomach cancer accounted for 723,000 deaths and breast cancer accounted for 521,000 deaths respectively in the year 2012 alone. Paclitaxel is used for the treatment of both these cancers and the rising incidences of cancer would result in increased use of this drug for treatment.

Paclitaxel Injection Market by Geography

Paclitaxel Injection Market is segmented geographically into North America, Europe, Asia Pacific and RoW. Currently the market is dominated by North America due to the high incidence of Cancer patients in this region. However, Europe and Asia Pacific are emerging markets due to rising incidences of cancer.


Paclitaxel injection market segmentation analysis and forecast 2020

MARKET OVERVIEW

Competitive analysis

The companies in this market are Abraxis Bio Science Inc., Celgene, Abbott Laboratories, Fresenius Kabi Oncology Ltd, Onco therapies Ltd, Novasep, Sagent Pharmaceuticals and others. The European Commission approved ABRAXANE to be taken in combination with Gentamicin for the treatment of metastatic pancreatic cancer in January 2014. ABRAXANE was developed by Celgene International SĂ rl, a subsidiary of Celgene Corporation.

High Level Analysis

Porter’s five force model analyzes the bargaining power of the suppliers and buyers as well as the threat of new entrants. The threat of substitutes in this market is high, with extensive research and development being carried out in anti-cancer drugs. SWOT analysis helps in making strategic decisions for development and expansion. The key drivers, restraints and opportunities are analyzed to help in better understanding the growth of this market.


Paclitaxel injection market segmentation analysis and forecast 2020

SUMMARY

Paclitaxel is used for the treatment of both these cancers and the rising incidences of cancer would result in increased use of this drug for treatment.

The companies in this market are Abraxis Bio Science Inc., Celgene, Abbott Laboratories, Fresenius Kabi Oncology Ltd, Onco therapies Ltd, Novasep, Sagent Pharmaceuticals and others. The European Commission approved ABRAXANE to be taken in combination with Gentamicin for the treatment of metastatic pancreatic cancer in January 2014. ABRAXANE was developed by Celgene International SĂ rl, a subsidiary of Celgene Corporation.

Enquiry For [email protected]://www.bigmarketresearch.com/report-enquiry/22831


Paclitaxel injection market segmentation analysis and forecast 2020

FOR MORE DETAILS

Visit us at :

www.bigmarketresearch.com

Stay With Us:

  • TELEPHONE: + 1-800-910-6452

  • EMAIL: [email protected]

  • 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States


  • Login